Q32 Bio, Inc. (QTTB)
11.05
-0.05
(-0.45%)
USD |
NASDAQ |
Sep 14, 10:56
Q32 Bio Market Cap : 262.29M for Sept. 14, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 263.48M |
| September 10, 2026 | 254.46M |
| September 09, 2026 | 264.43M |
| September 08, 2026 | 277.48M |
| September 04, 2026 | 284.60M |
| September 03, 2026 | 303.83M |
| September 02, 2026 | 322.58M |
| September 01, 2026 | 340.86M |
| August 31, 2026 | 352.96M |
| August 28, 2026 | 356.76M |
| August 27, 2026 | 383.35M |
| August 26, 2026 | 384.06M |
| August 25, 2026 | 387.38M |
| August 24, 2026 | 388.33M |
| August 21, 2026 | 379.07M |
| August 20, 2026 | 376.46M |
| August 19, 2026 | 375.99M |
| August 18, 2026 | 362.93M |
| August 17, 2026 | 378.60M |
| August 14, 2026 | 359.61M |
| August 13, 2026 | 364.83M |
| August 12, 2026 | 364.83M |
| August 11, 2026 | 365.78M |
| August 10, 2026 | 371.95M |
| August 07, 2026 | 370.29M |
| Date | Value |
|---|---|
| August 06, 2026 | 384.53M |
| August 05, 2026 | 391.42M |
| August 04, 2026 | 383.46M |
| August 03, 2026 | 359.97M |
| July 31, 2026 | 229.39M |
| July 30, 2026 | 227.64M |
| July 29, 2026 | 214.18M |
| July 28, 2026 | 229.83M |
| July 27, 2026 | 222.51M |
| July 24, 2026 | 221.64M |
| July 23, 2026 | 225.00M |
| July 22, 2026 | 220.61M |
| July 21, 2026 | 225.44M |
| July 20, 2026 | 220.03M |
| July 17, 2026 | 220.17M |
| July 16, 2026 | 222.51M |
| July 15, 2026 | 229.68M |
| July 14, 2026 | 270.06M |
| July 13, 2026 | 312.78M |
| July 10, 2026 | 164.00M |
| July 09, 2026 | 184.19M |
| July 08, 2026 | 205.98M |
| July 07, 2026 | 199.25M |
| July 06, 2026 | 188.21M |
| July 02, 2026 | 191.50M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Beam Therapeutics, Inc. | 2.521B |
| Prelude Therapeutics, Inc. | 370.87M |
| Intellia Therapeutics, Inc. | 1.661B |
| Twist Bioscience Corp. | 8.039B |
| Revolution Medicines, Inc. | 43.27B |
Market Cap Related Metrics
| PE Ratio | 3.682 |
| PS Ratio | 3.047 |
| Price to Book Value | 2.477 |
| Price | 11.05 |
| Earnings Yield | 27.16% |
| Operating PE Ratio | 7.629 |
| Normalized PE Ratio | 3.676 |